Abstract
Although numerous chemokines act on monocytes, none of them is specific for these cells. Here, we show that breast and kidney-expressed chemokine (BRAK) is a highly selective monocyte chemoattractant. Migration efficacy and Bordetella pertussis toxin-sensitive Ca(2+) mobilization responses to BRAK were strongly enhanced after treatment of monocytes with the cyclic AMP-elevating agents prostaglandin E(2) and forskolin. BRAK is the first monocyte-selective chemokine, as other types of blood leukocytes or monocyte-derived dendritic cells and macrophages did not respond. Expression in normal skin keratinocytes and dermal fibroblasts as well as lamina propria cells in normal intestinal tissues suggests a homeostatic rather than an inflammatory function for this chemokine. In addition, macrophages were frequently found to colocalize with BRAK-producing fibroblasts. We propose that BRAK is involved in the generation of tissue macrophages by recruiting extravasated precursors to fibroblasts, which are known to secrete essential cytokines for macrophage development.
MeSH Terms
Cell Differentiation
Cell Movement
Cells, Cultured
Chemokines, CXC/genetics,physiology
Cyclic AMP/metabolism
Humans
Intestinal Mucosa/metabolism
Kidney/metabolism
Leukocytes, Mononuclear/cytology,metabolism,physiology
Macrophages/cytology
Monocytes/cytology,drug effects,metabolism,physiology
Pertussis Toxin
Receptors, Chemokine/metabolism
Signal Transduction
Tissue Distribution
Virulence Factors, Bordetella/metabolism,pharmacology
Chemicals
CXCL14 protein, human
Chemokines, CXC
Receptors, Chemokine
Virulence Factors, Bordetella
Cyclic AMP
Pertussis Toxin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kurth I
Theodor-Kocher Institute, University of Bern, CH-3000 Bern 9, Switzerland.
Willimann K
Schaerli P
Hunziker T
Clark-Lewis I
Moser B
References (24)
24 references, click to expand
-
Chemokines and their receptors in lymphocyte traffic and HIV infection.
Adv Immunol. 2000;74:127-80
PMID: 10605606
-
Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing.
J Immunol. 1999 Aug 1;163(3):1246-52
PMID: 10415020
-
Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1.
FASEB J. 2000 Apr;14(5):661-8
PMID: 10744623
-
B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine.
Int Immunol. 2000 May;12(5):677-89
PMID: 10784614
-
In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue.
Am J Pathol. 2000 Jun;156(6):1937-50
PMID: 10854217
-
Mechanical control of cyclic AMP signalling and gene transcription through integrins.
Nat Cell Biol. 2000 Sep;2(9):666-8
PMID: 10980709
-
CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.
J Exp Med. 2000 Dec 4;192(11):1553-62
PMID: 11104798
-
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages.
Nat Immunol. 2000 Dec;1(6):510-4
PMID: 11101873
-
Lymphocyte traffic control by chemokines.
Nat Immunol. 2001 Feb;2(2):123-8
PMID: 11175804
-
A novel neutrophil-activating factor produced by human mononuclear phagocytes.
J Exp Med. 1988 May 1;167(5):1547-59
PMID: 2835419
-
cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness.
J Immunol. 1991 Jan 1;146(1):224-32
PMID: 1701793
-
Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.
Biochemistry. 1991 Mar 26;30(12):3128-35
PMID: 2007144
-
Characterization of the inhibitory prostanoid receptors on human neutrophils.
Br J Pharmacol. 1993 Apr;108(4):1051-4
PMID: 8387383
-
Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E2.
J Immunol. 1994 Jun 15;152(12):5703-13
PMID: 8207201
-
Enhanced expression of IL-8 in normal human keratinocytes and human keratinocyte cell line HaCaT in vitro after stimulation with contact sensitizers, tolerogens and irritants.
Exp Dermatol. 1994 Dec;3(6):298-303
PMID: 7749573
-
Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin.
J Exp Med. 1996 May 1;183(5):2379-84
PMID: 8642349
-
IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells.
J Immunol. 1997 Jul 1;159(1):28-35
PMID: 9200435
-
Elevation of intracellular cAMP inhibits RhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants.
J Biol Chem. 1997 Sep 26;272(39):24141-4
PMID: 9305861
-
Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate.
Blood. 1998 Jul 1;92(1):40-5
PMID: 9639497
-
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation.
Eur J Immunol. 1998 Sep;28(9):2760-9
PMID: 9754563
-
Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking.
Science. 1998 Oct 16;282(5388):480-3
PMID: 9774276
-
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.
Blood. 1998 Dec 15;92(12):4778-91
PMID: 9845545
-
Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells.
Biochem Biophys Res Commun. 1999 Feb 24;255(3):703-6
PMID: 10049774
-
International union of pharmacology. XXII. Nomenclature for chemokine receptors.
Pharmacol Rev. 2000 Mar;52(1):145-76
PMID: 10699158